Browsing "1. Journal Papers" by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 6581 to 6600 of 13735

This table browses all dspace content
Issue DateTitleJournal Title
2020Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction KOREAN JOURNAL OF INTERNAL MEDICINE
2003Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-α or -γ agonists in a type 2 diabetic animal modelDIABETES-METABOLISM RESEARCH AND REVIEWS
2015Leiomyosarcoma: investigation of prognostic factors for risk-stratification modelINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2021Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity BLOOD RESEARCH
2013Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells ONCOLOGY LETTERS
2014Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patientsANNALS OF HEMATOLOGY
2023Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort StudyTHYROID
2020Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in KoreaTHYROID
2021Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2019Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale FUTURE ONCOLOGY
2021Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaNEW ENGLAND JOURNAL OF MEDICINE
2023Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label studyLANCET ONCOLOGY
2013Leptin/Adiponectin Ratio Is an Independent Predictor of Mortality in Nondiabetic Peritoneal Dialysis Patients PERITONEAL DIALYSIS INTERNATIONAL
2001Leptomeningeal Carcinomatosis in Solid Tumors ; Clinical Manifestation and Treatment Journal of the Korean Cancer Association (대한암학회지)
2020Lesion-Based Convolutional Neural Network in Diagnosis of Early Gastric Cancer CLINICAL ENDOSCOPY
2019Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective StudyTHYROID
2020Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort studyEUROPEAN HEART JOURNAL
2017Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.ONCOLOGY
2014Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years WORLD JOURNAL OF SURGICAL ONCOLOGY
2021Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis GUT AND LIVER

Browse

Links